RGD Reference Report - Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Clinical importance of serum interleukin-18 and nitric oxide activities in breast carcinoma patients.

Authors: Gunel, N  Coskun, U  Sancak, B  Gunel, U  Hasdemir, O  Bozkurt, S 
Citation: Gunel N, etal., Cancer. 2002 Aug 1;95(3):663-7.
RGD ID: 8655866
Pubmed: PMID:12209760   (View Abstract at PubMed)
DOI: DOI:10.1002/cncr.10705   (Journal Full-text)

BACKGROUND: Interleukin-18 (IL-18) is a novel immunoregulatory cytokine that was known previously as interferon-gamma-inducing factor. IL-18 levels can be used as a serum indicator for monitoring the clinical course of patients with hematologic malignancies and gastric carcinoma. Nitric oxide (NO) is a pleiotropic molecule that participates in the multistep processing of carcinogenesis. METHODS: In the current study, we measured serum IL-18 and nitrate and nitrite levels in 38 metastatic and 26 nonmetastatic breast carcinoma patients and 16 healthy control subjects. Serum nitrate and nitrite levels were measured as an index of NO generation. RESULTS: The levels of serum IL-18 and nitrate and nitrite were increased significantly in breast carcinoma patients compared with control subjects (P < 0.001). Serum IL-18 levels were significantly higher in the metastatic patients compared with the nonmetastatic patients (P < 0.001). There was no difference in serum nitrate and nitrite levels between metastatic and nonmetastatic patients (P > 0.05). Patients with bone metastasis have higher serum IL-18 levels and lower serum nitrate and nitrite levels compared with patients with liver, lung, and local metastasis (P < 0.001). There was no correlation among serum IL-18, nitrate and nitrite, CA 15-3, and carcinoembryonic antigen levels (P > 0.05). CONCLUSIONS: These findings suggest that serum IL-18 and nitrate and nitrite levels may be useful markers in monitoring metastatic breast carcinoma patients. IL-18 and NO activities in breast carcinoma patients with bone metastasis may be more valuable in the follow-up of these patients.



RGD Manual Disease Annotations    Click to see Annotation Detail View

  
Object SymbolSpeciesTermQualifierEvidenceWithNotesSourceOriginal Reference(s)
IL18Humanbreast cancer  IEP protein:increased expression:serumRGD 
Il18Ratbreast cancer  ISOIL18 (Homo sapiens)protein:increased expression:serumRGD 
Il18Mousebreast cancer  ISOIL18 (Homo sapiens)protein:increased expression:serumRGD 
IL18HumanNeoplasm Metastasis  IEP associated with breast cancer and protein:increased expression:serumRGD 
Il18RatNeoplasm Metastasis  ISOIL18 (Homo sapiens)associated with breast cancer and protein:increased expression:serumRGD 
Il18MouseNeoplasm Metastasis  ISOIL18 (Homo sapiens)associated with breast cancer and protein:increased expression:serumRGD 

Objects Annotated

Genes (Rattus norvegicus)
Il18  (interleukin 18)

Genes (Mus musculus)
Il18  (interleukin 18)

Genes (Homo sapiens)
IL18  (interleukin 18)


Additional Information